Quatech

Quatech is a biotechnology and pharmaceutical company specializing in the development of innovative therapies derived from natural sources and bioactive venoms. The company's portfolio includes patented wound-healing treatments for chronic conditions such as diabetic foot ulcers and bedsores, as well as herbal-based anti-cancer and anti-aging supplements. Quatech is also actively researching venom-derived compounds for use in anti-rheumatoid medications and antidotes, alongside a specialized platform for CNS 'shuttle drugs' targeting neurodegenerative conditions like Multiple Sclerosis and Parkinson's. Through its partnership with Gorgio International Holding, Quatech focuses on translating scientific research into scalable medical solutions for global health challenges.